The present invention relates to a pharmaceutical combination of a glycine transporter inhibitor (GlyT1) and an atypical antipsychotic drug which may be used for the treatment of positive and negative symptoms of schizophrenia.
申请公布号
WO2012019970(A1)
申请公布日期
2012.02.16
申请号
WO2011EP63533
申请日期
2011.08.05
申请人
F. HOFFMANN-LA ROCHE AG;ALBERATI, DANIELA;MOREAU, JEAN-LUC;WETTSTEIN, JOSEPH G.
发明人
ALBERATI, DANIELA;MOREAU, JEAN-LUC;WETTSTEIN, JOSEPH G.
